September 2026
The rare musculoskeletal disorder treatments market is growing as innovation targets therapies for underserved and complex conditions.
September 2026
The global circadian rhythm sleep disorders market size was evaluated at USD 2.90 billion in 2026 and is predicted to hit around USD 5.25 billion by 2035, growing at a CAGR of 6.80%.
September 2026
The global opioid use disorder market size is estimated to hit around USD 16.75 billion by 2035, increasing from USD 6.56 billion in 2026, with a CAGR of 11.00%.
September 2026
The near infrared absorbing materials market size is predicted to reach around USD 722.31 million by 2034 from USD 366.95 million in 2026 with a solid CAGR of 7.83%.
September 2026
The rare earth minerals market established a strong position in 2026 and is projected to expand significantly from 2026 through 2035, driven by increasing demand, evolving market needs, technological advancements, and growing adoption across key industries..
September 2026
The rare disease small-batch CDMO market is expanding with demand for specialized manufacturing of orphan drugs and niche therapies.
September 2026
The global non-dispersive infrared market size is valued at USD 808.14 million in 2026 and is estimated to hit around USD 1391.66 million by 2034 with a CAGR of 7.03%.
September 2026
The next-gen dermatology treatments market established a strong position in 2026 and is projected to expand significantly from 2026 through 2035, driven by increasing demand, evolving market needs, technological advancements, and growing adoption across key industries.
September 2026
The australia rare earth minerals market established a strong position in 2026 and is projected to expand significantly from 2026 through 2035, driven by increasing demand, evolving market needs, technological advancements, and growing adoption across key industries..
September 2026
The autoimmune neurological disorders market generated USD 9.17 billion in 2026, with prominent autoimmune neurological disorders market companies including Biogen Inc., F. Hoffmann-La Roche Ltd., Novartis AG, Sanofi S.A.
September 2026
The stem cell therapy for neurological disorders market generated USD 17.90 billion in 2026, with prominent stem cell therapy for neurological disorders market companies including BrainStorm Cell Therapeutics, Mesoblast, ReNeuron Group.
September 2026
The global rare earth metals market size reached USD 4.55 billion in 2026 and is projected to surpass around USD 10.83 billion by 2035, with a solid CAGR of 10.12%.
September 2026
By Laxmi Narayan-Aug 2026-the military electro-optical and infrared systems market was valued at USD 10.25 billion in 2026, expanding at a CAGR of 4.97% by 2035.
September 2026
By Gautam Mahajan - Aug 2026 - the infrared and thermal imaging systems market was valued at USD 8.35 billion in 2025, expanding at a CAGR of 7.89% by 2035.
July 2026
The sleep disorder market size was estimated at USD 31.79 billion in 2025 and is predicted to be worth around USD 94.82 billion by 2035 with a CAGR of 11.55%.
July 2026
The next gen cardiovascular treatments market established a strong position in 2026 and is projected to expand significantly from 2026 through 2035, driven by increasing demand, evolving market needs, technological advancements, and growing adoption across key industries..
July 2026
The global medical aesthetic treatments market growth is fueled by advancements in laser technology, injectables, and rising patient preference for aesthetic care.
June 2026
The global neurological rare disease biologics market is growing as advanced biologics address unmet needs in rare neurological disorders.
June 2026
The global respiratory disorders treatment market size is estimated to surpass around USD 218.05 billion by 2035 from USD 128.39 billion in 2026 with a CAGR of 6.07%.
June 2026
The rare diseases treatment market size was estimated at USD 244.57 billion in 2025 and is predicted to hit around USD 566.83 billion by 2035 with a CAGR of 8.77%.
June 2026
The global knee osteoarthritis injectable treatments market size is estimated to hit around USD 6.78 billion by 2035 from USD 3.70 billion in 2026, with a CAGR of 6.96%.
April 2026
The global hyperpigmentation disorder treatment market size is estimated to hit around USD 12.28 billion by 2035 increasing from USD 6.19 billion in 2025, with a CAGR of 7.09%.
February 2026
The global rare cell isolation market size was estimated at USD 2.25 billion in 2025 and is expected to hit around USD 5.63 billion by 2035, growing at a CAGR of 9.61% from 2026 to 2035.
January 2026
The global infrared countermeasures system market size was evaluated at USD 9.59 billion in 2025 and is predicted to hit around USD 15.36 billion by 2035, growing at a CAGR of 4.82%.
December 2025
The global gastric motility disorder drug market is surging, with an overall revenue growth expectation of hundreds of millions of dollars from 2025 to 2035.
December 2025
The global post-traumatic stress disorder treatment market size is projected to hit around USD 3.55 billion by 2035 from USD 2.37 billion in 2025, with a CAGR of 4.12%.
July 2025
The global autism spectrum disorder treatment market size was valued at USD 2.64 billion in 2026 and is expected to hit around USD 4.22 billion by 2034, at a CAGR of 6.03%.
July 2026
The psoriatic arthritis therapeutics drugs market is growing with rising demand for biologics, biosimilars, and advanced targeted treatment options.
August 2025
The global spinal imaging market size was calculated at USD 2.09 billion in 2024 and is predicted to attain around USD 3.49 billion by 2034, with a CAGR of 5.26%.
August 2025
The global human chorionic gonadotropin market size is projected to surge around USD 2.94 billion by 2034 from USD 2.15 billion in 2024, with a CAGR of 3.20%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com